Gary Titus - Net Worth and Insider Trading
Gary Titus Net Worth
The estimated net worth of Gary Titus is at least $413,609 dollars as of 2024-05-21. Gary Titus is the Senior VP Finance & CFO of SciClone Pharmaceuticals Inc and owns about 37,095 shares of SciClone Pharmaceuticals Inc (SCLN) stock worth over $413,609. Details can be seen in Gary Titus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary Titus has not made any transactions after 2012-06-15 and currently still holds the listed stock(s).
Transaction Summary of Gary Titus
Gary Titus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary Titus owns 3 companies in total, including EOM Pharmaceutical Holdings Inc (IMUC) , SciClone Pharmaceuticals Inc (SCLN) , and ARCA biopharma Inc (ABIO) .
Click here to see the complete history of Gary Titus’s form 4 insider trades.
Insider Ownership Summary of Gary Titus
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMUC | EOM Pharmaceutical Holdings Inc | 2016-06-17 | director & Chairman and Secretary |
| SCLN | SciClone Pharmaceuticals Inc | 2012-06-15 | Senior VP Finance & CFO |
| ABIO | ARCA biopharma Inc | 2004-07-23 | V.P. and Chief Acctg Officer |
Gary Titus Latest Holdings Summary
Gary Titus currently owns a total of 1 stock. Gary Titus owns 37,095 shares of SciClone Pharmaceuticals Inc (SCLN) as of June 15, 2012, with a value of $413,609.
Latest Holdings of Gary Titus
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCLN | SciClone Pharmaceuticals Inc | 2012-06-15 | 37,095 | 11.15 | 413,609 |
Holding Weightings of Gary Titus
Gary Titus Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary Titus has made a total of 0 transactions in SciClone Pharmaceuticals Inc (SCLN) over the past 5 years. The most-recent trade in SciClone Pharmaceuticals Inc is the sale of 81,607 shares on June 15, 2012, which brought Gary Titus around $571,249.
Insider Trading History of Gary Titus
- 1
Gary Titus Trading Performance
GuruFocus tracks the stock performance after each of Gary Titus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary Titus is 17.66%. GuruFocus also compares Gary Titus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary Titus within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary Titus's insider trading performs compared to the benchmark.
Performance of Gary Titus
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.06 | | | | | |
| Relative Return to S&P 500(%) | 1.12 | | | | | |
Gary Titus Ownership Network
Gary Titus Owned Company Details
What does EOM Pharmaceutical Holdings Inc do?
Who are the key executives at EOM Pharmaceutical Holdings Inc?
Gary Titus is the director & Chairman and Secretary of EOM Pharmaceutical Holdings Inc. Other key executives at EOM Pharmaceutical Holdings Inc include VP & Product Development & Mfg. James G. Bender , and director & President & CEO Manish Singh .
EOM Pharmaceutical Holdings Inc (IMUC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of EOM Pharmaceutical Holdings Inc (IMUC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EOM Pharmaceutical Holdings Inc (IMUC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
EOM Pharmaceutical Holdings Inc (IMUC)'s detailed insider trading history can be found in Insider Trading Tracker table.
EOM Pharmaceutical Holdings Inc Insider Transactions
Gary Titus Mailing Address
Above is the net worth, insider trading, and ownership report for Gary Titus. You might contact Gary Titus via mailing address: Sciclone Pharmaceuticals, Inc., 950 Tower Lane, Suite 900, Foster City Ca 94404-2125.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
